<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Osgood-Schlatter disease (tibial tuberosity avulsion)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Osgood-Schlatter disease (tibial tuberosity avulsion)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Osgood-Schlatter disease (tibial tuberosity avulsion)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew J Kienstra, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles G Macias, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William A Phillips, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan I Singer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joshua Nagler, MD, MHPEd</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Grayzel, MD, FAAEM</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Osgood-Schlatter disease, also known as osteochondritis of the tibial tubercle, was first described in 1903 [<a href="#rid1">1,2</a>]. It is a traction apophysitis of the proximal tibial tubercle at the insertion of the patellar tendon.</p><p>The clinical features and management of Osgood-Schlatter disease will be discussed here. Causes of knee pain and the general approach to the diagnosis of knee pain in children and adolescents are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6514.html" rel="external">"Approach to acute knee pain and injury in children and skeletally immature adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/6515.html" rel="external">"Approach to chronic knee pain or injury in children or skeletally immature adolescents"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>Osgood-Schlatter disease is characterized by pain and swelling at the tibial tubercle, the point of insertion of the patellar tendon  (<a class="graphic graphic_figure graphicRef54565" href="/z/d/graphic/54565.html" rel="external">figure 1</a> and <a class="graphic graphic_picture graphicRef91025" href="/z/d/graphic/91025.html" rel="external">picture 1</a> and <a class="graphic graphic_figure graphicRef51102" href="/z/d/graphic/51102.html" rel="external">figure 2</a> and <a class="graphic graphic_picture graphicRef89737" href="/z/d/graphic/89737.html" rel="external">picture 2</a>). The patellar tendon arises from the inferior pole of the patella, a sesamoid bone within the quadriceps tendon. The quadriceps muscle is involved in knee extension.</p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Osgood-Schlatter disease generally occurs in children 9 to 14 years of age who have undergone a rapid growth spurt. According to a 2022 systematic review of four studies, prevalence among children between the ages of 12 and 15 years (n = 956) was 9.83 percent (95% CI 8.02-11.90) [<a href="#rid3">3</a>]. Among adolescents, the condition develops approximately twice as often in those who are active in sports compared with nonathletes [<a href="#rid3">3,4</a>]. It is bilateral in 25 to 50 percent of cases, although involvement is typically asymmetric [<a href="#rid4">4-6</a>].</p><p>Osgood-Schlatter has traditionally occurred most commonly in boys. However, it is becoming more common in girls as their sports participation increases [<a href="#rid7">7</a>]. While the rate was higher in males in the review cited above, there was no statistically significant difference in prevalence between males (n = 474), 11.39 percent (95% CI 8.68-14.60), and females (n = 482), 8.3 percent (95% CI 5.99-11.13) [<a href="#rid3">3</a>]. Osgood-Schlatter typically occurs one to two years earlier in girls than in boys, corresponding to the different timing of the pubertal growth spurt. (See  <a class="medical medical_review" href="/z/d/html/5849.html" rel="external">"Normal puberty", section on 'Growth spurt'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Osgood-Schlatter occurs most frequently in participants of sports that involve running, cutting (rapid change of direction while running), and jumping (eg, football (soccer), American football, basketball, volleyball, gymnastics, figure skating, ballet) [<a href="#rid8">8,9</a>]. These activities place stress on the tibial tubercle through repetitive contraction of the quadriceps muscle.</p><p class="headingAnchor" id="H5"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Osgood-Schlatter disease is an overuse injury caused by repetitive strain and chronic avulsion of the secondary ossification center (apophysis) of the tibial tubercle [<a href="#rid10">10-14</a>]. Chronic avulsion causes separation of the proximal patellar tendon insertion from the tibial tubercle, which results in elevation  (<a class="graphic graphic_figure graphicRef73362" href="/z/d/graphic/73362.html" rel="external">figure 3</a>). As callous is laid down during healing, the tubercle may become markedly pronounced. (See <a class="local">'Complications and sequelae'</a> below.)</p><p>Other factors that may be related to the development of Osgood-Schlatter disease include a more proximal attachment of the patellar tendon [<a href="#rid15">15</a>], attachment to a broader area of the tibia [<a href="#rid15">15</a>], a history of calcaneal apophysitis (Sever syndrome) [<a href="#rid4">4</a>], and a high-riding patella (patella alta) [<a href="#rid16">16</a>]. Patella alta requires increased force from the quadriceps for full extension, which may contribute to apophyseal stress [<a href="#rid16">16</a>]. However, the temporal relationship between patella alta and Osgood-Schlatter has not been established, and it is possible that patella alta is the effect, rather than the cause, of Osgood-Schlatter [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>Osgood-Schlatter typically occurs in the 13 to 14-year-old boy or skeletally equivalent 11 to 12-year-old girl who has recently undergone a rapid growth spurt [<a href="#rid18">18</a>].</p><p>The most common presenting complaint is anterior knee pain that increases gradually over time, from a low-grade ache to pain that causes a limp and/or impairs activity [<a href="#rid19">19</a>]. Pain is exacerbated by direct trauma, kneeling, running, jumping, squatting, climbing stairs, or walking uphill, and is relieved by rest. Involvement usually is asymmetric, although both knees are involved in 25 to 50 percent of cases [<a href="#rid4">4,5,10</a>].</p><p class="headingAnchor" id="H7"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>The diagnosis of Osgood-Schlatter disease is made by clinical examination. Radiographs are not necessary unless the patient has atypical complaints (pain at night, pain that is unrelated to activity, acute onset of pain, associated systemic complaints) or pain that is not directly over the tibial tubercle. (See <a class="local">'Imaging'</a> below and <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H8"><span class="h2">Examination</span><span class="headingEndMark"> — </span>A description of the complete knee examination for children and adolescents is provided separately. (See  <a class="medical medical_review" href="/z/d/html/6514.html" rel="external">"Approach to acute knee pain and injury in children and skeletally immature adolescents", section on 'Physical examination'</a>.)</p><p>The characteristic examination findings of Osgood-Schlatter disease include tenderness and soft tissue or bony prominence of the tibial tubercle  (<a class="graphic graphic_picture graphicRef122898" href="/z/d/graphic/122898.html" rel="external">picture 3</a>) [<a href="#rid18">18</a>]. Pain may be reproduced by extending the knee against resistance, stressing the quadriceps, or squatting with the knee in full flexion [<a href="#rid20">20</a>]. Straight-leg raising usually is painless. Pain that is more prominent in the patellar tendon than the bony prominence is suggestive of patellar tendinopathy (jumper's knee) [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/13812.html" rel="external">"Quadriceps muscle and tendon injuries", section on 'Clinical presentation and examination'</a>.)</p><p>The hamstrings may be shortened and the quadriceps taut. Quadriceps flexibility is assessed by passively flexing the knee with the patient prone (ie, the Ely test)  (<a class="graphic graphic_figure graphicRef64226" href="/z/d/graphic/64226.html" rel="external">figure 4</a>). The range of motion of the knee is not affected, and the knee and patellofemoral joints are stable [<a href="#rid20">20,22</a>]. The remainder of the knee examination is usually normal.</p><p>Erythema and warmth of the tibial tubercle, which suggest an acute inflammatory process, require additional evaluation (eg, for osteomyelitis). However, these findings must be interpreted with caution in patients who have used an ace wrap or heating pad before presenting for evaluation [<a href="#rid22">22,23</a>].</p><p>Examination of patients with knee pain should include evaluation of range of motion of the hip to make sure that the knee pain is not related to referred pain from pathology in the hip (eg, due to slipped capital femoral epiphysis, Legg-Calvé-Perthes disease) [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/2856.html" rel="external">"Approach to hip pain in childhood", section on 'Examination'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>The majority of patients do not require imaging for diagnosis or treatment of Osgood-Schlatter disease.</p><p>Ultrasonography has been described as potentially aiding diagnosis, delineating pathogenesis, defining risk factors, and managing patients with Osgood-Schlatter disease [<a href="#rid25">25-31</a>]. However, most patients can be diagnosed and managed without point of care ultrasound.</p><p>Plain radiographs are appropriate to help exclude other conditions (eg, tibial apophyseal fracture, tumors, or osteomyelitis) in patients who have atypical features [<a href="#rid22">22-24</a>] (see <a class="local">'Differential diagnosis'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Erythema or warmth in addition to pain at the tibial tubercle is suggestive of an inflammatory process, such as osteomyelitis. (See  <a class="medical medical_review" href="/z/d/html/6064.html" rel="external">"Hematogenous osteomyelitis in children: Clinical features and complications", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute onset of pain (particularly after an injury) may indicate avulsion fracture of the tibial tubercle [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/z/d/html/205.html" rel="external">"Proximal tibial fractures in adults", section on 'Tibial tubercle avulsions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pain at night, rest-related pain, mechanical symptoms (catching or locking), associated systemic complaints, and/or tenderness that is not directly localized to the tibial tubercle may indicate tumor, infection, or osteochondritis dissecans. (See  <a class="medical medical_review" href="/z/d/html/6243.html" rel="external">"Overview of common presenting signs and symptoms of childhood cancer", section on 'Bone and joint pain'</a> and  <a class="medical medical_review" href="/z/d/html/6064.html" rel="external">"Hematogenous osteomyelitis in children: Clinical features and complications", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/17003.html" rel="external">"Osteochondritis dissecans (OCD): Clinical manifestations, evaluation, and diagnosis", section on 'Clinical presentation'</a>.)</p><p></p><p>The radiographic findings of Osgood-Schlatter disease are best depicted on the lateral radiograph. The findings are nonspecific and must be correlated with clinical findings to make the diagnosis. Soft tissue swelling anterior to the tibial tubercle may be the only abnormality  (<a class="graphic graphic_diagnosticimage graphicRef65651" href="/z/d/graphic/65651.html" rel="external">image 1</a>). Other signs may include [<a href="#rid8">8,20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Elevation of the tubercle away from the shaft  (<a class="graphic graphic_diagnosticimage graphicRef122896" href="/z/d/graphic/122896.html" rel="external">image 2</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Irregularity, fragmentation, or increased density of the tubercle  (<a class="graphic graphic_diagnosticimage graphicRef122896" href="/z/d/graphic/122896.html" rel="external">image 2</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>A superficial ossicle in the patellar tendon</p><p class="bulletIndent1"><span class="glyph">●</span>Calcification within or thickening of the patellar tendon</p><p></p><p>These findings may be difficult to distinguish from normal variation in the ossification of the tubercle. One or more ossicles may be present but may be normal variants [<a href="#rid33">33</a>]. Changes in the surrounding soft tissues and the infrapatellar fat pad may be more reliable diagnostic features [<a href="#rid34">34</a>].</p><p>Magnetic resonance imaging (MRI) has been proposed as a means of classifying staging of Osgood-Schlatter disease, which may help with prognosis, but it is usually not indicated [<a href="#rid13">13,35</a>]. In consultation with an orthopedic surgeon, or sports medicine specialist, MRI may be appropriate for evaluating young adults who are symptomatic beyond the growth period, particularly those patients with severe symptoms refractory to conservative treatment.</p><p>Because other imaging modalities can provide similar or better information regarding the status of the apophysis with no or less radiation, computed tomography imaging is not indicated in patients with Osgood-Schlatter disease.</p><p class="headingAnchor" id="H10"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Osgood-Schlatter is one in a spectrum of conditions that cause anterior knee pain in children and adolescents [<a href="#rid20">20,36</a>].</p><p>Bone tumors (eg, Ewing sarcoma, osteogenic sarcoma, osteoid osteoma, osteoblastoma, eosinophilic granuloma, and enchondroma) and subacute osteomyelitis of the proximal tibial apophysis rarely cause anterior knee pain in children and adolescents [<a href="#rid37">37,38</a>]. These conditions usually have associated features that are absent in patients with Osgood-Schlatter (eg, pain at night, rest-related pain, erythema and/or warmth over the tibial tubercle, fever and other systemic complaints). Patients who have such atypical features should undergo imaging as part of the initial evaluation. (See <a class="local">'Imaging'</a> above.)</p><p>Other conditions that cause anterior knee pain in children and adolescents include:</p><p class="bulletIndent1"><span class="glyph">●</span>Stress fracture of the proximal tibia</p><p class="bulletIndent1"><span class="glyph">●</span>Quadriceps tendon avulsion</p><p class="bulletIndent1"><span class="glyph">●</span>Avulsion fracture of the tibial tubercle</p><p class="bulletIndent1"><span class="glyph">●</span>Peripatellar tendinopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Sinding-Larsen-Johansson (traction apophysitis at the inferior pole of the patella that typically occurs in boys aged 9 to 11 years)</p><p class="bulletIndent1"><span class="glyph">●</span>Plica syndrome (inflammation of the synovial folds)</p><p class="bulletIndent1"><span class="glyph">●</span>Hoffa disease (impingement of the infrapatellar fat pad)</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic anterior knee pain</p><p></p><p>Tenderness over the tibial tubercle usually distinguishes Osgood-Schlatter from the above conditions, in which such tenderness is rarely present. The exception is avulsion fracture of the tibial tubercle, in which there is generally a history of acute injury [<a href="#rid32">32</a>]. The evaluation of patients with anterior knee pain that is not localized to the tibial tubercle is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6514.html" rel="external">"Approach to acute knee pain and injury in children and skeletally immature adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/6515.html" rel="external">"Approach to chronic knee pain or injury in children or skeletally immature adolescents"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of Osgood-Schlatter disease has not been studied in randomized controlled trials [<a href="#rid39">39</a>]. Observational studies suggest that most patients respond to nonsurgical treatment and that those with persistent symptoms may benefit from surgical therapy (eg, ossicle excision) [<a href="#rid4">4,5,10,40-42</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Nonsurgical treatment</span><span class="headingEndMark"> — </span>Osgood-Schlatter disease typically is a benign and self-limited condition. Symptoms generally resolve once the growth plate is ossified. The usual course is 6 to 18 months, during which symptoms may wax and wane [<a href="#rid24">24,43</a>]. However, some patients may have prolonged pain that may interfere with sports participation and quality of life. (See <a class="local">'Prognosis'</a> below.)</p><p>Conservative measures are the mainstay of therapy. Conservative measures for Osgood-Schlatter disease include control of pain and swelling, continuation of activity, and physical therapy (to strengthen the quadriceps and improve quadriceps and hamstring flexibility). The efficacy of these measures for patients with Osgood-Schlatter has not been evaluated in randomized trials [<a href="#rid39">39</a>]. The recommendations below are based upon observational studies and clinical experience [<a href="#rid4">4,5,10,40-42</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Pain control</span><span class="headingEndMark"> — </span>Measures to control pain and swelling may include the application of ice, administration of analgesics and/or nonsteroidal  (<a class="graphic graphic_diagnosticimage graphicRef65651" href="/z/d/graphic/65651.html" rel="external">image 1</a>) antiinflammatory drugs (NSAIDS) for a limited duration (eg, three to four days), and the wearing of a protective pad over the tibial tubercle.</p><p>The application of ice to the involved area after participating in sports activity may be helpful in reducing pain and swelling [<a href="#rid39">39</a>]. During periods of symptom exacerbation, ice should be applied for 20 to 30 minutes at a time at least twice per day.</p><p>Analgesics (eg, <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">acetaminophen</a>) or nonsteroidal antiinflammatory medications (eg, <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">ibuprofen</a>) may help to control the pain.</p><p>Patients with persistent pain that alters their ability to participate in sports for more than three months may benefit from injection of hyperosmolar dextrose (eg, 12.5 percent dextrose) by a sports medicine specialist or orthopedic surgeon. As an example, in a small blinded trial of 54 young athletes (mean age 13 years) with Osgood-Schlatter disease and persistent pain despite three months of usual care (ie, local pain control, oral analgesics, and strengthening and stretching exercises with gradual sports reintroduction), injection of 12.5 percent dextrose mixed with <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">lidocaine</a> was significantly associated with no symptoms during sports activities at three months and one year when compared to lidocaine injection or usual care [<a href="#rid44">44</a>]. Although these results are encouraging, additional study is necessary to clarify any potential adverse events before this procedure can be routinely recommended.</p><p>Glucocorticoid injections generally are not recommended because of case reports of complications, primarily related to subcutaneous atrophy [<a href="#rid45">45</a>].</p><p>Wearing a protective pad over the tibial tubercle (an Osgood-Schlatter pad, or a brace with a doughnut pad around the tibial tubercle) may prevent direct trauma to the tender tibial tubercle [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H14"><span class="h3">Activity continuation</span><span class="headingEndMark"> — </span>Complete avoidance of sports activity is neither necessary nor recommended [<a href="#rid46">46</a>]. Inactivity can lead to deconditioning and increases the risk of recurrence or other injury after returning to sports participation [<a href="#rid24">24</a>].</p><p>Osgood-Schlatter is one condition in which playing with pain is permitted (provided the pain is tolerated and resolves within 24 hours [<a href="#rid24">24</a>]). Activities that require prolonged squatting or kneeling may not be tolerated; for some athletes, a change in position may be necessary (eg, from catcher to outfielder in baseball) [<a href="#rid43">43,47</a>].</p><p>Crutches are rarely indicated, and knee immobilizers are contraindicated. Extended periods of casting worsen the ultimate outcome because they lead to atrophy of the quadriceps and hamstring muscles.</p><p class="headingAnchor" id="H15"><span class="h3">Physical therapy</span><span class="headingEndMark"> — </span>Once pain is adequately controlled, athletes with Osgood-Schlatter disease should participate in a rehabilitative program that includes stretching and strengthening of the quadriceps and hamstring muscles [<a href="#rid24">24,48</a>].</p><p class="headingAnchor" id="H16"><span class="h3">Education</span><span class="headingEndMark"> — </span>Children and adolescents with Osgood-Schlatter disease and their parents should be educated regarding the anticipated disease course. They should understand that during the course of resolution, there may be unpredictable exacerbations of symptoms that resolve quickly with appropriate management [<a href="#rid24">24,43</a>]. They should also understand that variable amounts of tibial tubercle prominence will persist after symptoms have resolved [<a href="#rid47">47</a>]. (See <a class="local">'Complications and sequelae'</a> below.)</p><p class="headingAnchor" id="H17"><span class="h3">Follow-up</span><span class="headingEndMark"> — </span>There is no specific follow-up schedule for patients with Osgood-Schlatter. Patients should follow-up with their primary care provider as regularly scheduled for health maintenance. They should make arrangements to be seen sooner if they have persistent or worsening pain or develop atypical features (a new or different type of pain, pain at night, pain that is unrelated to activity, or associated systemic complaints).</p><p class="headingAnchor" id="H18"><span class="h2">Surgical treatment</span><span class="headingEndMark"> — </span>Surgical management is reserved for patients who fail to respond to conservative measures; it is generally undertaken after closure of the proximal tibial growth plate [<a href="#rid42">42</a>]. Specific procedures have not been evaluated in randomized trials. In case series, ossicle resection and/or excision of the tibial tuberosity have been beneficial in reducing symptoms [<a href="#rid10">10,42,49-52</a>]. Arthroscopy is favored over an open approach because it decreases the risk of damage to the patellar tendon, permits more rapid return to activity, avoids a scar over the tuberosity that can cause pain with kneeling, and has better cosmesis [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H19"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Osgood-Schlatter disease typically subsides with the closure of the proximal tibial growth plate at skeletal maturity (usually between 14 and 18 years of age). However, a subset of adolescents may experience prolonged pain that may be associated with diminished athletic function and quality of life [<a href="#rid54">54-56</a>]. Pain that persists after the closure of the growth plate may be related to a residual ossicle [<a href="#rid23">23</a>]. </p><p>The natural history of Osgood-Schlatter disease was evaluated in a retrospective review of 50 patients (69 knees) for whom no treatments or activity restrictions were recommended [<a href="#rid5">5</a>]. After an average of nine years, 24 percent of patients reported some limitation in activities, and 60 percent had discomfort with kneeling.</p><p class="headingAnchor" id="H20"><span class="h1">COMPLICATIONS AND SEQUELAE</span><span class="headingEndMark"> — </span>Complications and sequelae of Osgood-Schlatter disease may include persistent prominence of the tibial tubercle, persistent pain, and rarely, genu recurvatum (back knee, hyperextension of the knee)  (<a class="graphic graphic_figure graphicRef51091" href="/z/d/graphic/51091.html" rel="external">figure 5</a>) [<a href="#rid24">24</a>].</p><p>Variable amounts of tibial tubercle prominence persist after symptoms have resolved [<a href="#rid47">47</a>]. Patients and parents should be informed about this potential cosmetic sequela at the time of diagnosis [<a href="#rid24">24,47</a>].</p><p>Pain that persists after closure of the proximal tibial growth plate is uncommon. A residual ossicle is the most common cause; avulsion fracture of the tibial tubercle is another possibility. Plain radiographs of the tibial tuberosity should be obtained if these injuries are suspected.</p><p>Residual ossicles in the patellar tendon occur in approximately 10 percent of children and adolescents with Osgood-Schlatter disease [<a href="#rid10">10,19</a>]. Residual ossicles may be associated with symptoms that persist after closure of the proximal tibial growth plate (eg, pain with activity or direct pressure) [<a href="#rid23">23</a>]. Ossicle excision can be curative [<a href="#rid10">10</a>]. (See <a class="local">'Surgical treatment'</a> above.)</p><p>Persistent pain that is not associated with a residual ossicle may indicate avulsion fracture of the tibial tubercle, particularly in athletes involved in jumping sports [<a href="#rid57">57</a>]. Tibial tubercle fractures occur more commonly among teenagers with a history of Osgood-Schlatter disease [<a href="#rid58">58</a>] but remain uncommon [<a href="#rid58">58,59</a>]. A causal relationship has not been demonstrated [<a href="#rid8">8</a>].</p><p>Genu recurvatum is a rare but serious complication of Osgood-Schlatter disease [<a href="#rid60">60,61</a>]. It results from premature fusion of the anterior part of the upper tibial epiphyseal plate.</p><p class="headingAnchor" id="H436114806"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/85878.html" rel="external">"Patient education: Osgood-Schlatter disease (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and pathogenesis</strong> – Osgood-Schlatter disease is an overuse injury seen in older children and adolescents. It is caused by repetitive strain and chronic avulsion of the secondary ossification center of the tibial tubercle. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Osgood-Schlatter occurs most frequently in participants of sports that involve running, cutting, and jumping, especially children and adolescents who have recently undergone a rapid growth spurt. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – The most common presenting complaint is anterior knee pain that increases gradually over time; the pain is exacerbated by direct trauma, kneeling, running, jumping, squatting, climbing stairs, or walking uphill, and is relieved by rest. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of Osgood-Schlatter is made clinically. The characteristic findings are tenderness and soft tissue or bony prominence of the tibial tubercle in a patient with an otherwise normal examination (including range of motion of the hip). (See <a class="local">'Examination'</a> above.)</p><p></p><p class="bulletIndent1">Imaging is not necessary to confirm the diagnosis in individuals with characteristic features but may be necessary to exclude other conditions in patients with atypical complaints, such as pain at night, rest-related pain, acute onset of pain (especially after trauma), associated systemic complaints, or pain that is not directly over the tibial tubercle. (See <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – For children and adolescents with Osgood-Schlatter disease, we suggest the following conservative measures (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>) (see <a class="local">'Nonsurgical treatment'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cold therapy (eg, applying ice) to the tibial tuberosity after participating in sporting activities. (See <a class="local">'Pain control'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Analgesics or nonsteroidal antiinflammatory drugs of limited duration (no longer than 3 to 4 days) as needed for pain. Patients with persistent pain that alters their ability to participate in sports for more than three months may benefit from injection of hyperosmolar dextrose (eg, 12.5 percent dextrose) by a sports medicine specialist or orthopedic surgeon. (See <a class="local">'Pain control'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continued sports participation, provided that the pain can be tolerated and resolves within 24 hours. (See <a class="local">'Activity continuation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Physical therapy to strengthen the quadriceps and stretch the quadriceps and hamstrings. (See <a class="local">'Physical therapy'</a> above.)</p><p></p><p class="bulletIndent1">Neither immobilization of the knee nor cessation of activity are appropriate.</p><p></p><p class="bulletIndent1">Children and adolescents with Osgood-Schlatter disease and their parents/caregivers require anticipatory guidance regarding the expected waxing and waning disease course, the typical duration of the disease, and its sequelae. (See <a class="local">'Education'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Complications and sequelae of Osgood-Schlatter disease may include persistent prominence of the tibial tubercle, persistent pain (usually related to a residual ossicle), and genu recurvatum. Patients who have pain that persists after closure of the proximal tibial growth plate and is related to bony or cartilaginous ossicles may benefit from surgical excision. (See <a class="local">'Complications and sequelae'</a> above and <a class="local">'Surgical treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – Osgood-Schlatter disease typically is a benign and self-limited condition, although a significant subset of patients may experience prolonged pain that may be associated with diminished athletic performance and quality of life. Symptoms generally resolve once the growth plate is ossified. (See <a class="local">'Prognosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Osgood, RB. Lesions of the tibial tubercle occurring during adolescence. Boston Med Surg J 1903; 148:114.</a></li><li><a class="nounderline abstract_t">Schlatter, C. Verletzungen des schnabelforminogen fortsatzes der oberen tibiaepiphyse. Beitre Klin Chir Tubing 1903; 38:874.</a></li><li><a class="nounderline abstract_t">Haines M, Pirlo L, Bowles KA, Williams CM. Describing Frequencies of Lower-Limb Apophyseal Injuries in Children and Adolescents: A Systematic Review. Clin J Sport Med 2022; 32:433.</a></li><li><a class="nounderline abstract_t">Kujala UM, Kvist M, Heinonen O. Osgood-Schlatter's disease in adolescent athletes. Retrospective study of incidence and duration. Am J Sports Med 1985; 13:236.</a></li><li><a class="nounderline abstract_t">Krause BL, Williams JP, Catterall A. Natural history of Osgood-Schlatter disease. J Pediatr Orthop 1990; 10:65.</a></li><li><a class="nounderline abstract_t">Stanitski CL. Knee overuse disorders in the pediatric and adolescent athlete. Instr Course Lect 1993; 42:483.</a></li><li><a class="nounderline abstract_t">Duri ZA, Patel DV, Aichroth PM. The immature athlete. Clin Sports Med 2002; 21:461.</a></li><li class="breakAll">Willis RB. Sports medicine in the growing child. In: Lovell and Winter's Pediatric Orthopaedics, 6th ed, Morrissey RT, Weinstein SL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1384.</li><li><a class="nounderline abstract_t">Cassas KJ, Cassettari-Wayhs A. Childhood and adolescent sports-related overuse injuries. Am Fam Physician 2006; 73:1014.</a></li><li><a class="nounderline abstract_t">Mital MA, Matza RA, Cohen J. The so-called unresolved Osgood-Schlatter lesion: a concept based on fifteen surgically treated lesions. J Bone Joint Surg Am 1980; 62:732.</a></li><li><a class="nounderline abstract_t">Gholve PA, Scher DM, Khakharia S, et al. Osgood Schlatter syndrome. Curr Opin Pediatr 2007; 19:44.</a></li><li><a class="nounderline abstract_t">Ogden JA, Southwick WO. Osgood-Schlatter's disease and tibial tuberosity development. Clin Orthop Relat Res 1976; :180.</a></li><li><a class="nounderline abstract_t">Hirano A, Fukubayashi T, Ishii T, Ochiai N. Magnetic resonance imaging of Osgood-Schlatter disease: the course of the disease. Skeletal Radiol 2002; 31:334.</a></li><li><a class="nounderline abstract_t">Rosenberg ZS, Kawelblum M, Cheung YY, et al. Osgood-Schlatter lesion: fracture or tendinitis? Scintigraphic, CT, and MR imaging features. Radiology 1992; 185:853.</a></li><li><a class="nounderline abstract_t">Demirag B, Ozturk C, Yazici Z, Sarisozen B. The pathophysiology of Osgood-Schlatter disease: a magnetic resonance investigation. J Pediatr Orthop B 2004; 13:379.</a></li><li><a class="nounderline abstract_t">Aparicio G, Abril JC, Calvo E, Alvarez L. Radiologic study of patellar height in Osgood-Schlatter disease. J Pediatr Orthop 1997; 17:63.</a></li><li><a class="nounderline abstract_t">Andrisano A, Mignani G, Mazzetti M. Long term results in Osgood-Schlatters disease. Ital J Orthop Traumatol 1985; 11:483.</a></li><li><a class="nounderline abstract_t">Clark, MC, Iwinski, HJ. The limping child: The challenges of an accurate assessment and diagnosis. Pediatr Emerg Med 1997; 2:123.</a></li><li class="breakAll">Micheli LJ. Osgood-Schlatter syndrome. In: The Sports Medicine Bible, Harper Perennial, New York 1995. p.137.</li><li><a class="nounderline abstract_t">Dunn JF. Osgood-Schlatter disease. Am Fam Physician 1990; 41:173.</a></li><li class="breakAll">Micheli LJ, Purcell L. Osgood-Schlatter disease. In: The Adolescent Athlete: A Practical Approach, Spring, New York 2007. p.311.</li><li class="breakAll">Osgood-Schlatter Disease. In: Essentials of Musculoskeletal Care, Greene WB (Ed), American Academy of Orthopedic Surgeons, Rosemont 2001. p.719.</li><li class="breakAll">Stahli LT. Sports. In: Fundamentals of Pediatric Orthopedics, 2nd ed, Lippincott Raven, Philadelphia 1998. p.111.</li><li><a class="nounderline abstract_t">Wall EJ. Osgood-schlatter disease: practical treatment for a self-limiting condition. Phys Sportsmed 1998; 26:29.</a></li><li><a class="nounderline abstract_t">De Flaviis L, Nessi R, Scaglione P, et al. Ultrasonic diagnosis of Osgood-Schlatter and Sinding-Larsen-Johansson diseases of the knee. Skeletal Radiol 1989; 18:193.</a></li><li><a class="nounderline abstract_t">Blankstein A, Cohen I, Heim M, et al. Ultrasonography as a diagnostic modality in Osgood-Schlatter disease. A clinical study and review of the literature. Arch Orthop Trauma Surg 2001; 121:536.</a></li><li><a class="nounderline abstract_t">Yanagisawa S, Osawa T, Saito K, et al. Assessment of Osgood-Schlatter Disease and the Skeletal Maturation of the Distal Attachment of the Patellar Tendon in Preadolescent Males. Orthop J Sports Med 2014; 2:2325967114542084.</a></li><li><a class="nounderline abstract_t">Nakase J, Aiba T, Goshima K, et al. Relationship between the skeletal maturation of the distal attachment of the patellar tendon and physical features in preadolescent male football players. Knee Surg Sports Traumatol Arthrosc 2014; 22:195.</a></li><li><a class="nounderline abstract_t">Nakase J, Goshima K, Numata H, et al. Precise risk factors for Osgood-Schlatter disease. Arch Orthop Trauma Surg 2015; 135:1277.</a></li><li><a class="nounderline abstract_t">Suzue N, Matsuura T, Iwame T, et al. State-of-the-art ultrasonographic findings in lower extremity sports injuries. J Med Invest 2015; 62:109.</a></li><li><a class="nounderline abstract_t">Sailly M, Whiteley R, Johnson A. Doppler ultrasound and tibial tuberosity maturation status predicts pain in adolescent male athletes with Osgood-Schlatter's disease: a case series with comparison group and clinical interpretation. Br J Sports Med 2013; 47:93.</a></li><li><a class="nounderline abstract_t">Chow SP, Lam JJ, Leong JC. Fracture of the tibial tubercle in the adolescent. J Bone Joint Surg Br 1990; 72:231.</a></li><li><a class="nounderline abstract_t">Bloom RA, Gomori J, Milgrom C. Ossicles anterior to the proximal tibia. Clin Imaging 1993; 17:137.</a></li><li><a class="nounderline abstract_t">Scotti DM, Sadhu VK, Heimberg F, O'Hara AE. Osgood-Schlatter's disease, an emphasis on soft tissue changes in roentgen diagnosis. Skeletal Radiol 1979; 4:21.</a></li><li><a class="nounderline abstract_t">Lee DW, Kim MJ, Kim WJ, et al. Correlation between Magnetic Resonance Imaging Characteristics of the Patellar Tendon and Clinical Scores in Osgood-Schlatter Disease. Knee Surg Relat Res 2016; 28:62.</a></li><li><a class="nounderline abstract_t">Schwend RM, Geiger J. Outpatient pediatric orthopedics. Common and important conditions. Pediatr Clin North Am 1998; 45:943.</a></li><li class="breakAll">Tachdijan MO. The knee and leg. In: Clinical Pediatric Orthopedics: The Art of Diagnosis and Principles of Management, Appleton and Lange, Stamford 1997. p.107.</li><li><a class="nounderline abstract_t">D'Ambrosia RD, MacDonald GL. Pitfalls in the diagnosis of Osgood-Schlatter disease. Clin Orthop Relat Res 1975; :206.</a></li><li><a class="nounderline abstract_t">Bloom OJ, Mackler L, Barbee J. Clinical inquiries. What is the best treatment for Osgood-Schlatter disease? J Fam Pract 2004; 53:153.</a></li><li><a class="nounderline abstract_t">Hussain, A, Hagroo, GA. Osgood-Schlatter disease. Sports Exer Injury 1996; 2:202.</a></li><li><a class="nounderline abstract_t">Beovich, R, Fricker, PA. Osgood-Schlatter's disease. A review of the literature and an Australian series. Aust J Sci Med Sport 1988; 20:11.</a></li><li><a class="nounderline abstract_t">Weiss JM, Jordan SS, Andersen JS, et al. Surgical treatment of unresolved Osgood-Schlatter disease: ossicle resection with tibial tubercleplasty. J Pediatr Orthop 2007; 27:844.</a></li><li class="breakAll">Stanitski CL. Patellofemoral mechanism. In: DeLee &amp; Drez's Orthopaedic Sports Medicine Principles and Practice, DeLee JC, Drez D, Miller MD (Eds), Saunders, Philadelphia 2003. p.1814.</li><li><a class="nounderline abstract_t">Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics 2011; 128:e1121.</a></li><li><a class="nounderline abstract_t">Rostron PK, Calver RF. Subcutaneous atrophy following methylprednisolone injection in Osgood-Schlatter epiphysitis. J Bone Joint Surg Am 1979; 61:627.</a></li><li class="breakAll">Tolo VT. The lower extremity. In: Lovell and Winter's Pediatric Orthopaedics, Morrissey RT, Weinstein SL (Eds), Lippincott- Raven, Philadelphia 1996. p.1063.</li><li class="breakAll">Neuschwander DC. Peripatellar pathology. In: DeLee &amp; Drez's Orthopaedic Sports Medicine Principles and Practice, 2nd ed, DeLee JC, Drez D, Miller MD (Eds), Saunders, Philadelphia 2003. p.1867.</li><li><a class="nounderline abstract_t">Ladenhauf HN, Seitlinger G, Green DW. Osgood-Schlatter disease: a 2020 update of a common knee condition in children. Curr Opin Pediatr 2020; 32:107.</a></li><li><a class="nounderline abstract_t">Orava S, Malinen L, Karpakka J, et al. Results of surgical treatment of unresolved Osgood-Schlatter lesion. Ann Chir Gynaecol 2000; 89:298.</a></li><li><a class="nounderline abstract_t">Flowers MJ, Bhadreshwar DR. Tibial tuberosity excision for symptomatic Osgood-Schlatter disease. J Pediatr Orthop 1995; 15:292.</a></li><li><a class="nounderline abstract_t">Binazzi R, Felli L, Vaccari V, Borelli P. Surgical treatment of unresolved Osgood-Schlatter lesion. Clin Orthop Relat Res 1993; :202.</a></li><li><a class="nounderline abstract_t">Pihlajamäki HK, Mattila VM, Parviainen M, et al. Long-term outcome after surgical treatment of unresolved Osgood-Schlatter disease in young men. J Bone Joint Surg Am 2009; 91:2350.</a></li><li><a class="nounderline abstract_t">Circi E, Atalay Y, Beyzadeoglu T. Treatment of Osgood-Schlatter disease: review of the literature. Musculoskelet Surg 2017; 101:195.</a></li><li><a class="nounderline abstract_t">Holden S, Olesen JL, Winiarski LM, et al. Is the Prognosis of Osgood-Schlatter Poorer Than Anticipated? A Prospective Cohort Study With 24-Month Follow-up. Orthop J Sports Med 2021; 9:23259671211022239.</a></li><li><a class="nounderline abstract_t">Guldhammer C, Rathleff MS, Jensen HP, Holden S. Long-term Prognosis and Impact of Osgood-Schlatter Disease 4 Years After Diagnosis: A Retrospective Study. Orthop J Sports Med 2019; 7:2325967119878136.</a></li><li><a class="nounderline abstract_t">Gaulrapp H, Nührenbörger C. The Osgood-Schlatter disease: a large clinical series with evaluation of risk factors, natural course, and outcomes. Int Orthop 2022; 46:197.</a></li><li class="breakAll">Bernhardt DT. Overuse injuries of the knee. In: Care of the Young Athlete, 2nd ed, Harris SS, Anderson SJ (Eds), American Academy of Orthopedic Surgeons, American Academy of Pediatrics, Elk Grove Village, Illinois 2010. p.421.</li><li><a class="nounderline abstract_t">Wiss DA, Schilz JL, Zionts L. Type III fractures of the tibial tubercle in adolescents. J Orthop Trauma 1991; 5:475.</a></li><li><a class="nounderline abstract_t">Bolesta MJ, Fitch RD. Tibial tubercle avulsions. J Pediatr Orthop 1986; 6:186.</a></li><li><a class="nounderline abstract_t">Lynch MC, Walsh HP. Tibia recurvatum as a complication of Osgood-Schlatter's disease: a report of two cases. J Pediatr Orthop 1991; 11:543.</a></li><li><a class="nounderline abstract_t">Bellicini C, Khoury JG. Correction of genu recurvatum secondary to Osgood-Schlatter disease: a case report. Iowa Orthop J 2006; 26:130.</a></li></ol></div><div id="topicVersionRevision">Topic 6289 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Lesions of the tibial tubercle occurring during adolescence</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Verletzungen des schnabelforminogen fortsatzes der oberen tibiaepiphyse</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34009802" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Describing Frequencies of Lower-Limb Apophyseal Injuries in Children and Adolescents: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4025675" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Osgood-Schlatter's disease in adolescent athletes. Retrospective study of incidence and duration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2298897" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Natural history of Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8463698" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Knee overuse disorders in the pediatric and adolescent athlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12365238" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The immature athlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12365238" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The immature athlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16570735" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Childhood and adolescent sports-related overuse injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7391096" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The so-called unresolved Osgood-Schlatter lesion: a concept based on fifteen surgically treated lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17224661" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Osgood Schlatter syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1277640" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Osgood-Schlatter's disease and tibial tuberosity development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12073117" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Magnetic resonance imaging of Osgood-Schlatter disease: the course of the disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1438775" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Osgood-Schlatter lesion: fracture or tendinitis? Scintigraphic, CT, and MR imaging features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15599229" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The pathophysiology of Osgood-Schlatter disease: a magnetic resonance investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8989704" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Radiologic study of patellar height in Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3830969" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Long term results in Osgood-Schlatters disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The limping child: The challenges of an accurate assessment and diagnosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The limping child: The challenges of an accurate assessment and diagnosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2403722" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2403722" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2403722" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2403722" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20086789" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Osgood-schlatter disease: practical treatment for a self-limiting condition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2665105" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ultrasonic diagnosis of Osgood-Schlatter and Sinding-Larsen-Johansson diseases of the knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11599758" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Ultrasonography as a diagnostic modality in Osgood-Schlatter disease. A clinical study and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26535345" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Assessment of Osgood-Schlatter Disease and the Skeletal Maturation of the Distal Attachment of the Patellar Tendon in Preadolescent Males.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23263228" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Relationship between the skeletal maturation of the distal attachment of the patellar tendon and physical features in preadolescent male football players.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26133498" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Precise risk factors for Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26399331" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : State-of-the-art ultrasonographic findings in lower extremity sports injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22952406" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Doppler ultrasound and tibial tuberosity maturation status predicts pain in adolescent male athletes with Osgood-Schlatter's disease: a case series with comparison group and clinical interpretation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2312561" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Fracture of the tibial tubercle in the adolescent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8348404" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ossicles anterior to the proximal tibia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/515746" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Osgood-Schlatter's disease, an emphasis on soft tissue changes in roentgen diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26955614" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Correlation between Magnetic Resonance Imaging Characteristics of the Patellar Tendon and Clinical Scores in Osgood-Schlatter Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9728195" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Outpatient pediatric orthopedics. Common and important conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9728195" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Outpatient pediatric orthopedics. Common and important conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1157384" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pitfalls in the diagnosis of Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14764303" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Clinical inquiries. What is the best treatment for Osgood-Schlatter disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Osgood-Schlatter disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A review of the literature and an Australian series</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17878797" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Surgical treatment of unresolved Osgood-Schlatter disease: ossicle resection with tibial tubercleplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17878797" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Surgical treatment of unresolved Osgood-Schlatter disease: ossicle resection with tibial tubercleplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21969284" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/438257" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Subcutaneous atrophy following methylprednisolone injection in Osgood-Schlatter epiphysitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/438257" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Subcutaneous atrophy following methylprednisolone injection in Osgood-Schlatter epiphysitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/438257" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Subcutaneous atrophy following methylprednisolone injection in Osgood-Schlatter epiphysitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31714260" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Osgood-Schlatter disease: a 2020 update of a common knee condition in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11204962" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Results of surgical treatment of unresolved Osgood-Schlatter lesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7790481" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Tibial tuberosity excision for symptomatic Osgood-Schlatter disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8472416" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Surgical treatment of unresolved Osgood-Schlatter lesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19797569" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Long-term outcome after surgical treatment of unresolved Osgood-Schlatter disease in young men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28593576" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Treatment of Osgood-Schlatter disease: review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34435066" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Is the Prognosis of Osgood-Schlatter Poorer Than Anticipated? A Prospective Cohort Study With 24-Month Follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31700938" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Long-term Prognosis and Impact of Osgood-Schlatter Disease 4 Years After Diagnosis: A Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34427770" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The Osgood-Schlatter disease: a large clinical series with evaluation of risk factors, natural course, and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34427770" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The Osgood-Schlatter disease: a large clinical series with evaluation of risk factors, natural course, and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1762011" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Type III fractures of the tibial tubercle in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3958174" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Tibial tubercle avulsions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1860961" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Tibia recurvatum as a complication of Osgood-Schlatter's disease: a report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16789463" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Correction of genu recurvatum secondary to Osgood-Schlatter disease: a case report.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
